Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Children with diabetes often have skin problems, which can be better managed with good blood sugar control.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Immune cells are crucial for normal skin development and their dysfunction can cause skin disorders.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Alopecia areata often appears on the scalp and is linked to various health issues, needing thorough evaluation.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Scalp lesions in discoid lupus are more common in women and linked to other autoimmune diseases.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Cleanroom workers in a battery factory have worse skin and eye conditions due to the very dry environment.